FUNDING$116M Series ABrainChild Bio Raises $116M for Kids' Brain Cancer TrialBrainChild Bio closed $116 million in Series A financing to fund a pivotal Phase 2 trial of its CAR T-cell therapy for DIPG, a rare and near-uniformly fatal pediatric brain tumor.Sep 8, 2026DEEP DIVE
